Use of isothiocyanate structural modified compound for preventing or treating liver disease
Provided is a use of an isothiocyanate structural modified compound in the manufacture of the pharmaceutical composition for preventing or treating a liver disease in a subject, and the pharmaceutical composition includes the isothiocyanate structural modified compound and a pharmaceutically accepta...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a use of an isothiocyanate structural modified compound in the manufacture of the pharmaceutical composition for preventing or treating a liver disease in a subject, and the pharmaceutical composition includes the isothiocyanate structural modified compound and a pharmaceutically acceptable carrier thereof. |
---|---|
Bibliography: | Application Number: TW202211139101 |